Search Results
Dr. Bekaii-Saab on an Analysis of IPMN and Pancreatic Cancer Outcomes
Dr. Bekaii-Saab on Immunotherapy and Viral Therapy for Pancreatic Cancer
Dr. Bekaii-Saab Discusses an Analysis of Bevacizumab or Cetuximab for CRC
Dr. Saab on a Phase II Study of the Oncolytic Virus Reolysin for Pancreatic Cancer
Dr. Bekaii-Saab Discusses an Analysis of Bevacizumab or Cetuximab for CRC
Dr. Bekaii-Saab on Second-Line Treatment Options in HCC
Clinical Research in the Treatment of Pancreas Cancer
Low progression of intraductal papillary mucinous neoplasms with worrisome features
Tanios Bekaii-Saab, MD, on developing effective immunotherapies in CRC patients
Dr. Bekaii Saab on the Expansion of Treatment Options in Colorectal Cancer
Tanios Bekaii-Saab, MD: Impact of Third-Line Therapy
Tanios Bekaii-Saab, MD: First-Line Treatments in Unresectable Colon Cancer
